Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

USFDA issues 15 observations for Jubilant HollisterStier General Partnership Montreal facility

Ruchika Sharma19 Jun 2024 11:15 AM IST

Noida: Jubilant Pharmova Limited has announced that the United States Food and Drug Administration (USFDA) has concluded the audit of the...

CDSCO Panel Approves Updated Package Insert for Takedas Vedolizumab

Takeda announces Phase 3 topline results for Soticlestat in patients with Dravet Syndrome, Lennox-Gastaut Syndrome

Ruchika Sharma18 Jun 2024 4:14 PM IST

Osaka: Takeda has announced topline data from its SKYLINE and SKYWAY studies. SKYLINE (TAK-935-3001) was a multicenter, randomized, double-blind...

Abhayrab Safe via Authorised Channels, Clarifies Indian Immunologicals Amid Fake Vaccine Alerts

Merck Capvaxive gets USFDA nod for prevention of Invasive Pneumococcal Disease, Pneumococcal Pneumonia in adults

Ruchika Sharma18 Jun 2024 2:04 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved...

Lupin ropes in Abdelaziz Toumi as CEO of its API CDMO Subsidiary

Ruchika Sharma18 Jun 2024 12:29 PM IST

Mumbai: Global pharma major Lupin Limited has announced the appointment of Abdelaziz Toumi (Abdel) as the Chief Executive Officer of its newly...

USFDA Approves Bionpharmas Generic HIV Drug Etravirine

USFDA approves Merck Keytruda plus Carboplatin, Paclitaxel for Primary Advanced or Recurrent Endometrial Carcinoma

Ruchika Sharma18 Jun 2024 11:30 AM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has approved...

USFDA approves Alembic Pharma Icatibant Injection for acute attacks of hereditary angioedema

Ruchika Sharma17 Jun 2024 3:29 PM IST

Icatibant injection is indicated for the treatment of acute attacks of hereditary angioedema in adults 18 years of age and older.

Himachal CM ensures State financial backing for bulk drug park project alongside Central aid to ensure timely completion

Ruchika Sharma17 Jun 2024 2:14 PM IST

Himachal Pradesh: Chief Minister Thakur Sukhvinder Singh Sukhu presided over a high level meeting here to review the progress of the...

AbbVie Loses India Patent Bid for Cancer Drug Venetoclax, Generics Set to Enter Market

AbbVie, FutureGen ink pact to develop Next-Generation Therapy for Inflammatory Bowel Disease

Ruchika Sharma17 Jun 2024 12:30 PM IST

North Chicago, IlI.: AbbVie and FutureGen Biopharmaceutical (Beijing) Co., Ltd. have announced a license agreement to develop FG-M701, a next...

AstraZeneca Pharma India Slapped Rs 11.88 Cr Tax Adjustment for FY23, to Move ITAT

AstraZeneca Imfinzi plus chemotherapy gets USFDA nod for mismatch repair deficient advanced or recurrent endometrial cancer

Ruchika Sharma17 Jun 2024 11:30 AM IST

Cambridge: AstraZeneca has announced that Imfinzi (durvalumab) in combination with carboplatin and paclitaxel followed by Imfinzi monotherapy has...

Biocon Gets USFDA Approval for Everolimus Oral Suspension in Pediatric, Adult TSC

USFDA issues 3 observations for Biocon Visakhapatnam API facility

Ruchika Sharma16 Jun 2024 11:00 AM IST

Bangalore: Biocon has informed in a BSE filing that the U.S. Food and Drug Administration (USFDA) has concluded...

Takeda signs option agreement with Ascentage Pharma to enter into exclusive global license for Olverembatinib

Ruchika Sharma16 Jun 2024 10:30 AM IST

Japan: Takeda has announced the signing of an option agreement with Ascentage Pharma to enter into an exclusive license agreement for...

JP Nadda, Anupriya Patel preside over review meeting of Department of Pharmaceuticals

Ruchika Sharma15 Jun 2024 5:32 PM IST

New Delhi: Union Minister for Chemicals & Fertilizers, Shri Jagat Prakash Nadda along with MoS (Chemicals & Fertilizers), Ms. Anupriya...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok